Nitroxyl donor
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 4, 2016 (NCT02932969)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bms-986231
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03891108 | Phase 1 | Feb 28, 2019 | Bristol-Myers Squibb |
| NCT03730961 | Phase 2 | Nov 27, 2018 | Bristol-Myers Squibb |
| NCT03515980 | Phase 1 | May 25, 2018 | Bristol-Myers Squibb |
| NCT03332186 | Phase 1 | Mar 15, 2018 | Bristol-Myers Squibb |
| NCT03357731 | Phase 2 | Nov 30, 2017 | Bristol-Myers Squibb |
| NCT03210909 | Phase 1 | Jun 22, 2017 | Bristol-Myers Squibb |
| NCT03016325 | Phase 2 | Jan 6, 2017 | Bristol-Myers Squibb |
| NCT02932969 | Phase 1 | Oct 4, 2016 | Bristol-Myers Squibb |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 8 | 8 | 2 | 2016 |
1 organizations
Page 1 / 1